Security
BioVie Inc. Warrant · BIVIW
BIVIWNASDAQWarrantCurrentCIK 1580149Updated Nov 6, 2026
Name history
NANOANTIBIOTICS, INC. · through Jul 22, 2016
BIVIW price & chart
Loading TradingView…
NASDAQ:BIVIW on TradingView ↗About the company
We are a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease.
In the news
No coverage from other publishers is available.
Recent filings
Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Regulation FD Disclosure
Items 1.01, 3.02, 7.01, 9.01
424B5 filing
424B5 filing
424B5 filing
DEF 14A filing
Show 5 more recent filings
Financials
FY 2026 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2026 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 17,514,621Source | 24,660,215Source | — | 22,503,293Source | 25,694,396Source | — | 26,820,098Source | — | 14,250,462Source | 21,562,199Source | 25,208,345Source | 35,104,730Source |
| GoodwillUSD | 345,711Source | 345,711Source | — | 345,711Source | 345,711Source | — | 345,711Source | — | 345,711Source | 345,711Source | 345,711Source | 345,711Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 6,308Source | 235,685Source | — | 63,653Source | 293,030Source | — | 120,997Source | — | — | 178,341Source | 407,718Source | 637,095Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 13,098,976Source | 23,152,014Source | — | 20,540,585Source | 24,405,517Source | — | 24,978,302Source | — | 8,977,370Source | 17,544,547Source | 23,843,798Source | 19,460,883Source |
| Assets, CurrentUSD | 16,879,692Source | 23,721,541Source | — | 21,791,434Source | 24,681,352Source | — | 26,031,990Source | — | 13,642,165Source | 20,698,494Source | 24,048,190Source | 34,041,135Source |
| Prepaid Expense and Other Assets, CurrentUSD | — | 569,527Source | — | — | 275,835Source | — | 873,884Source | — | — | 1,049,897Source | — | — |
| Operating Lease, Right-of-Use AssetUSD | 282,910Source | 357,278Source | — | 302,495Source | 374,303Source | — | 321,400Source | — | 262,586Source | 339,653Source | 406,726Source | 80,789Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 1,907,029Source | 2,842,270Source | — | 3,238,259Source | 1,771,817Source | — | 1,899,094Source | — | 3,980,192Source | 2,550,214Source | 9,702,130Source | 19,764,444Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 754Source | 7,463Source | — | 754Source | 7,456Source | — | 754Source | — | 754Source | 7,476Source | 6,229Source | 3,643Source |
| Retained Earnings (Accumulated Deficit)USD | -368,615,121Source | -348,655,105Source | — | -363,344,822Source | -345,866,687Source | — | -357,275,347Source | — | -374,260,653Source | -352,144,246Source | -334,232,661Source | -301,225,705Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | — | — | — | — | — | — | — | — | — | — | — | 176,591Source |
| Stockholders' Equity Attributable to ParentUSD | 15,607,592Source | 21,817,945Source | 18,925,927Source | 19,265,034Source | 23,922,579Source | 7,491,235Source | 24,921,004Source | 14,067,085Source | 10,270,270Source | 19,011,985Source | 15,506,215Source | 15,340,286Source |
| Additional Paid in Capital, Common StockUSD | 384,221,988Source | 370,465,616Source | — | 382,609,131Source | 369,781,837Source | — | 382,195,626Source | — | 384,530,198Source | 371,148,784Source | 349,732,674Source | 316,385,759Source |
| Liabilities and EquityUSD | 17,514,621Source | 24,660,215Source | — | 22,503,293Source | 25,694,396Source | — | 26,820,098Source | — | 14,250,462Source | 21,562,199Source | 25,208,345Source | 35,104,730Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 1,693,710Source | 2,546,553Source | — | 3,005,742Source | 1,456,902Source | — | 1,644,721Source | — | 3,795,771Source | 2,274,784Source | 9,352,236Source | 14,494,669Source |
| Operating Lease, Liability, CurrentUSD | 82,398Source | 70,713Source | — | 82,398Source | 67,111Source | — | 78,357Source | — | 91,009Source | 74,464Source | 60,343Source | 44,909Source |
| Accounts Payable, CurrentUSD | 1,611,312Source | 2,475,840Source | — | 2,923,344Source | 1,382,501Source | — | 1,566,364Source | — | 3,704,762Source | 2,200,320Source | 3,586,912Source | 3,476,259Source |
| Operating Lease, Liability, NoncurrentUSD | 213,319Source | 295,717Source | — | 232,517Source | 314,915Source | — | 254,373Source | — | 184,421Source | 275,430Source | 349,894Source | 42,505Source |
cash flow · annual statements
| Line item | Q4 2026 | Q4 2025 | Q3 2026 | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | -5,270,299Source | -2,788,418Source | -6,069,475Source | -7,112,529Source | -5,087,557Source | -4,152,032Source | -22,072,863Source | -17,542,120Source | -32,120,533Source | -50,255,815Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 268,388Source | 118,898Source | 2,283,809Source | 1,195,447Source | 2,823,764Source | 4,222,845Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | -633,956Source | -133,940Source | 1,504,442Source | -1,386,592Source | 110,653Source | 1,033,455Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -3,023,874Source | -3,579,456Source | -19,024,806Source | -19,025,205Source | -27,945,024Source | -40,252,881Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | — | — | — | — | 14,525,000Source | -14,301,135Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 10,457,629Source | -240,937Source | 10,457,629Source | 12,725,954Source | 17,802,939Source | 55,373,183Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 13,098,976Source | 23,152,014Source | 20,540,585Source | 24,405,517Source | 24,978,302Source | 20,023,405Source | 8,977,370Source | 17,544,547Source | 23,843,798Source | 19,460,883Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | 136,992Source | 17,901Source | 183,930Source | 1,525,056Source | 2,106,491Source |
| Additional Financial Items | ||||||||||||
| AmortizationUSD | — | — | — | — | — | — | 57,000Source | 57,000Source | 178,000Source | 229,000Source | — | — |
| Amortization of Debt Issuance CostsUSD | — | — | — | — | — | 2,000Source | — | — | — | 12,000Source | 109,000,000Source | 170,000Source |
| Amortization of Intangible AssetsUSD | — | — | 57,344Source | 57,344Source | 57,344Source | 57,344Source | 57,344Source | 57,344Source | 178,341Source | 229,377Source | 229,377Source | 229,377Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | — | — | — | — | — | — | — | 2,517Source | — | 3,771Source | 1,816,271Source | -1,437,481Source |
| Gain (Loss) on Sale of DerivativesUSD | — | — | — | 7,290Source | — | -6,036Source | — | 2,517Source | — | 3,771Source | 1,816,271Source | -1,437,481Source |
| General and Administrative ExpenseUSD | — | — | 2,151,088Source | 1,585,869Source | 1,935,482Source | 2,530,679Source | — | — | 8,511,032Source | — | — | — |
| GoodwillUSD | — | — | 345,711Source | 345,711Source | 345,711Source | 345,711Source | 345,711Source | — | 345,711Source | 345,711Source | 345,711Source | 345,711Source |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| InterestExpenseNonoperatingUSD | — | — | — | 4,998Source | — | 66,700Source | 1,989Source | 256,024Source | — | 332,720Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -5,270,299Source | -2,788,418Source | -6,069,475Source | -7,112,529Source | -5,087,557Source | -4,152,032Source | -22,072,863Source | -17,542,120Source | -32,120,533Source | -50,255,815Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | -33,006,956Source | -50,255,815Source |
| Nonoperating Income (Expense)USD | — | — | 115,078Source | 199,786Source | 192,830Source | 180,300Source | 197,038Source | -29,950Source | 578,870Source | 524,080Source | 59,052Source | — |
| Operating ExpensesUSD | — | — | 5,385,377Source | 2,988,204Source | 6,262,305Source | 7,292,829Source | 5,284,595Source | 4,122,082Source | 22,651,733Source | 18,066,200Source | 32,179,585Source | 45,080,448Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 10,457,629Source | 2,259,063Source | 10,457,629Source | 15,674,613Source | 27,802,939Source | 49,465,103Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | — | — | — | 2,240Source |
income statement · annual statements
| Line item | Q4 2026 | Q4 2025 | Q3 2026 | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General and Administrative ExpenseUSD | — | — | — | 1,585,869Source | — | 2,530,679Source | 2,290,881Source | 2,074,540Source | — | 8,570,089Source | 8,849,814Source | 11,551,568Source |
| Operating Income (Loss)USD | — | — | -5,385,377Source | -2,988,204Source | -6,262,305Source | -7,292,829Source | -5,284,595Source | -4,122,082Source | -22,651,733Source | -18,066,200Source | -32,179,585Source | -45,080,448Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -5,270,299Source | -2,788,418Source | -6,069,475Source | -7,112,529Source | -5,087,557Source | -4,152,032Source | -22,072,863Source | -17,542,120Source | -32,120,533Source | -50,255,815Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.7Source | -1.51Source | -0.77Source | -4.55Source | -0.98Source | -7Source | -3.05Source | -12.12Source | -7.3Source | -1.55Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.7Source | -1.51Source | -0.77Source | -4.55Source | -0.98Source | -7Source | -3.05Source | -12.12Source | -7.3Source | -1.55Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 7,543,923Source | 1,850,722Source | 7,920,795Source | 1,571,725Source | 5,214,355Source | 639,836Source | 7,245,928Source | 1,477,372Source | 4,518,533Source | 32,483,489Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 7,543,923Source | 1,850,722Source | 7,920,795Source | 1,571,725Source | 5,214,355Source | 639,836Source | 7,245,928Source | 1,477,372Source | 4,518,533Source | 32,483,489Source |
| Interest Expense (non-operating)USD | — | — | — | 4,998Source | — | 66,700Source | 1,989Source | 256,024Source | — | 332,720Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 57,344Source | 57,344Source | 57,344Source | 57,344Source | 57,344Source | 57,344Source | 178,341Source | 229,377Source | 229,377Source | 229,377Source |
| General and Administrative ExpenseUSD | — | — | 2,151,088Source | 1,585,869Source | 1,935,482Source | 2,530,679Source | — | — | 8,511,032Source | — | — | — |
| Income (Loss) Attributable to Parent, before TaxUSD | — | — | -5,270,299Source | -2,788,418Source | -6,069,475Source | -7,156,953Source | -5,131,101Source | -4,477,073Source | -22,116,407Source | -17,911,585Source | -33,006,956Source | -50,255,815Source |
| Interest ExpenseUSD | — | — | 5,967Source | 4,998Source | 5,967Source | 66,700Source | — | — | 17,901Source | — | 2,893,922Source | 4,300,150Source |
| Interest Expense, DebtUSD | — | — | — | — | — | 62,000Source | — | — | — | 312,000Source | 2,900,000Source | 4,300,000Source |
| Interest Income, OtherUSD | — | — | 121,045Source | 197,494Source | 198,797Source | 253,036Source | 199,027Source | 223,557Source | 596,771Source | 853,029Source | 1,136,703Source | 562,264Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | -33,006,956Source | -50,255,815Source |
| Nonoperating Income (Expense)USD | — | — | 115,078Source | 199,786Source | 192,830Source | 180,300Source | 197,038Source | -29,950Source | 578,870Source | 524,080Source | 59,052Source | — |
| Operating ExpensesUSD | — | — | 5,385,377Source | 2,988,204Source | 6,262,305Source | 7,292,829Source | 5,284,595Source | 4,122,082Source | 22,651,733Source | 18,066,200Source | 32,179,585Source | 45,080,448Source |
| Other IncomeUSD | — | — | — | — | — | — | 197,000Source | -30,000Source | 579,000Source | -524,000Source | — | — |
| Research and Development ExpenseUSD | — | — | 3,176,945Source | 1,344,991Source | 4,269,479Source | 4,704,806Source | 2,936,370Source | 1,990,198Source | 13,962,360Source | 9,266,734Source | 23,100,394Source | 33,299,503Source |
Offerings
Registration 333-297552
Registration 333-296924
Registration 333-288525
Underwriters: ThinkEquity LLC
Filing attachments
bivi-424b5ex107.htm · 424B5 · 2026-11-05
Calculation of Filing Fee Tables S-3 BIOVIE INC. N/A EX-FILING FEES Table 1: Newly Registered and Carry Forward Securities ☑Not Applicable ─────────────────────────────────────────────────────────────────────────────── Security Security Fee Amount Proposed Maximum Fee Rate Amount of Carry Forward Carry Forward Carry Forward Filing Fee …
Read attachment ↗bivi-424b5ex107.htm · 424B5 · 2026-09-14
Ex-Filing Fees CALCULATION OF FILING FEE TABLES S-3 BioVie Inc. Narrative Disclosure The maximum aggregate amount of the securities to which the prospectus relates is 6,464,341. The prospectus is a final prospectus for the related offering. The maximum aggregate offering price of the securities to which the prospectus relates is $6,464,341. The prospectus is a final prospectus for the related offering. The prospectus supplement to which this exhibit is attached is a final prospectus for th…
Read attachment ↗bivi_s1a3ex107.htm · S-1/A · 2026-08-14
Ex-Filing Fees CALCULATION OF FILING FEE TABLES S-1 BioVie Inc. Table 1: Newly Registered and Carry Forward Securities Line Item Type Security Type Security Class Title Notes Fee Calculation Amount Registered Proposed Maximum Offering Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee …
Read attachment ↗bivi_s1ex107.htm · S-1 · 2026-07-17
Ex-Filing Fees CALCULATION OF FILING FEE TABLES S-1 BioVie Inc. Table 1: Newly Registered and Carry Forward Securities Line Item Type Security Type Security Class Title Notes Fee Calculation Amount Registered Proposed Maximum Offering Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee …
Read attachment ↗bivi_s3ex107.htm · S-3 · 2026-06-18
Ex-Filing Fees CALCULATION OF FILING FEE TABLES S-3 BIOVIE INC. Table 1: Newly Registered and Carry Forward Securities Line Item Type Security Type Security Class Title Notes Fee Calculation Amount Registered Proposed Maximum Offering Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee …
Read attachment ↗bivi_s1ex107.htm · S-1 · 2025-07-03
EX-FILING FEES 10 bivi_s1ex107.htm CALCULATION OF FILING FEE TABLES Exhibit 107 Calculation of Filing Fee Tables FORM S-1 (Form Type) BIOVIE INC. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Security Class Title Fee Amount Proposed Maximum Fee Rate Amount of …
Read attachment ↗